GERK, PHILLIP M.,BARR, WILLIAM H.,RITTER, JOSEPH K.
申请号：
PE0004202014
公开号：
PE20432014A1
申请日:
2012.09.27
申请国别(地区):
PE
年份:
2014
代理人:
摘要：
Referring to an oral dose composition, characterised in that it comprises: a bioactive is selected from the group of phenylephrine, albuterol, magnolol, among others, and one or more Enzyme inhibitor selected from the group consisting of Quercetin, VANILLIN, eugenol, among others. It also refers to a method to provide orally the composition to a subject.REFERIDO A UNA COMPOSICION DE DOSIS ORAL, CARACTERIZADA PORQUE COMPRENDE: UN BIOACTIVO QUE SE SELECCIONA DEL GRUPO DE FENILEFRINA, ALBUTEROL, MAGNOLOL, ENTRE OTROS, Y UNO O MAS INHIBIDORES ENZIMATICOS SELECCIONADOS DEL GRUPO QUE CONSISTE DE QUERCETINA, VAINILLINA, EUGENOL, ENTRE OTROS. TAMBIEN SE REFIERE A UN METODO PARA PROPORCIONAR ORALMENTE DICHA COMPOSICION A UN SUJETO.
